Media coverage
11
Media coverage
Title Aeglea BioTherapeutics Announces Publication Of 20 Week Data From Phase 1/2 And Open-Label Extension Studies Of Pegzilarginase For The Treatment Of Arginase 1 Deficiency In The Journal Of Inherited Metabolic Disease Media name/outlet TheStreet.com Country/Territory United States Date 14/07/21 URL https://www.thestreet.com/press-releases/aeglea-biotherapeutics-announces-publication-of-20-week-data-from-phase-1-2-and-open-label-extension-studies-of-pegzilarginase-for-the-treatment-of-arginase-1-deficiency-in-the-journal-of-inherited-metabolic-disease-15712272 Persons George Diaz Title Aeglea BioTherapeutics Announces Publication of 20 Week Data from Phase 1/2 and Open-Label Extension Studies of Pegzilarginase for the Treatment of Arginase 1 Deficiency in the Journal of Inherited Metabolic Disease Media name/outlet Morningstar.com Country/Territory United States Date 14/07/21 URL https://www.morningstar.com/news/pr-newswire/20210714da43657/aeglea-biotherapeutics-announces-publication-of-20-week-data-from-phase-12-and-open-label-extension-studies-of-pegzilarginase-for-the-treatment-of-arginase-1-deficiency-in-the-journal-of-inherited-metabolic-disease Persons George Diaz Title Aeglea BioTherapeutics Announces Publication of 20 Week Data from Phase 1/2 and Open-Label Extension Studies of Pegzilarginase for the Treatment of Arginase 1 Deficiency in the Journal of Inherited Metabolic Disease Media name/outlet PR Newswire Country/Territory United States Date 14/07/21 Persons George Diaz Title Aeglea BioTherapeutics Announces Publication of 20 Week Data from Phase 1/2 and Open-Label Extension Studies of Pegzilarginas... Media name/outlet ADVFN UK Country/Territory United Kingdom Date 14/07/21 URL https://uk.advfn.com/stock-market/NASDAQ/AGLE/share-news/Aeglea-BioTherapeutics-Announces-Publication-of-20/85589267 Persons George Diaz Title Aeglea BioTherapeutics Announces Publication of 20 Week Data from Phase 1/2 and Open-Label Extension Studies of Pegzilarginase for the Treatment of Arginase 1 Deficiency in the Journal of Inherite... Media name/outlet Finanzen.net Country/Territory Germany Date 14/07/21 URL https://www.finanzen.net/nachricht/aktien/aeglea-biotherapeutics-announces-publication-of-20-week-data-from-phase-1-2-and-open-label-extension-studies-of-pegzilarginase-for-the-treatment-of-arginase-1-deficiency-in-the-journal-of-inherite-10333392 Persons George Diaz Title Aeglea BioTherapeutics Announces Publication of 20 Week Data from Phase 1/2 and Open-Label Extension Studies of Pegzilarginase for the Treatment of Arginase 1 Deficiency in the Journal of Inherited Metabolic Disease Media name/outlet Yahoo! Finance Country/Territory United States Date 14/07/21 URL https://finance.yahoo.com/news/aeglea-biotherapeutics-announces-publication-20-203000456.html Persons George Diaz Title Aeglea BioTherapeutics : Announces Publication of 20 Week Data from Phase 1/2 and Open-Label Extension Studies of Pegzilarginase for the Treatment of Arginase 1 Deficiency in the Journal of Inherited Metabolic Disease Media name/outlet MarketScreener.com Country/Territory United States Date 14/07/21 URL https://www.marketscreener.com/quote/stock/AEGLEA-BIOTHERAPEUTICS-I-27114072/news/Aeglea-BioTherapeutics-nbsp-Announces-Publication-of-20-Week-Data-from-Phase-1-2-and-Open-Label-Ex-35861290/ Persons George Diaz Title Aeglea BioTherapeutics Announces Publication of 20 Week Data from Phase 1/2 and Open-Label Extension Studies of Pegzilarginase for the Treatment of Arginase 1 Deficiency in the Journal of Inherited Metabolic Disease Media name/outlet ProfitQuotes.com Country/Territory United States Date 14/07/21 URL www.profitquotes.com/cgi/?a=news&ticker=a&w=&story=202107202107141630PR_NEWS_USPR_____DA43657 Persons George Diaz Title Aeglea BioTherapeutics Announces Publication of 20 Week Data from Phase 1/2 and Open-Label Extension Studies of Pegzilarginase for the Treatment of Arginase 1 Deficiency in the Journal of Inherited Metabolic Disease Media name/outlet TickerTech.com Country/Territory United States Date 14/07/21 URL www.tickertech.com/cgi/?a=news&ticker=a&w=&story=202107202107141630PR_NEWS_USPR_____DA43657 Persons George Diaz Title Aeglea BioTherapeutics Announces Publication of 20 Week Data from Phase 1/2 and Open-Label Extension Studies of Pegzilarginase for the Treatment of Arginase 1 Deficiency in the Journal of Inherite... Media name/outlet Finanzen.ch Country/Territory Switzerland Date 14/07/21 URL https://www.finanzen.ch/nachrichten/aktien/aeglea-biotherapeutics-announces-publication-of-20-week-data-from-phase-1-2-and-open-label-extension-studies-of-pegzilarginase-for-the-treatment-of-arginase-1-deficiency-in-the-journal-of-inherite--1030608314 Persons George Diaz Title Aeglea BioTherapeutics Announces Publication of 20 Week Data from Phase 1/2 and Open-Label Extension Studies of Pegzilarginase for the Treatment of Arginase 1 Deficiency in the Journal of Inherited Metabolic Disease Media name/outlet WFMZ-TV Online Country/Territory United States Date 14/07/21 URL https://www.wfmz.com/news/pr_newswire/pr_newswire_health/aeglea-biotherapeutics-announces-publication-of-20-week-data-from-phase-1-2-and-open-label/article_d3307b17-7de9-59c4-8099-1d4bd49155c7.html Persons George Diaz